Quantum Biopharma (QNTM) Net Income (2019 - 2026)
Quantum Biopharma recorded quarterly Net Income of -$3.0 million in Q1 2026, down 18.08% quarter-over-quarter from -$2.5 million in Q4 2025, and up 12.59% year-over-year from -$2.7 million in Q1 2025.
Quantum Biopharma's Net Income history runs 8 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- In Q1 2026, Net Income rose 12.59% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$15.3 million (down 15.88% YoY), while the FY2025 annual figure was -$15.5 million, changed N/A from the prior year.
- Net Income came in at -$3.0 million for Q1 2026 at Quantum Biopharma, down from -$2.5 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $25.3 million in Q2 2023 to a low of -$9.8 million in Q1 2023.
- A 5-year average of -$1.9 million and a median of -$3.4 million in 2023 frame the typical range for Net Income.
- Across the five-year window, Net Income slumped 2114.96% in 2023 and surged 76.95% in 2024, its largest moves.
- Quantum Biopharma's Net Income stood at -$444506.0 in 2022, then slumped by 1517.43% to -$7.2 million in 2023, then jumped by 70.88% to -$2.1 million in 2024, then dropped by 20.93% to -$2.5 million in 2025, then slipped by 18.08% to -$3.0 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$3.0 million, -$2.5 million, and -$4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -453.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.99 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | -4.77 Mn |
| Jun 30, 2025 | -4.97 Mn |
| Mar 31, 2025 | -3.42 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Sep 30, 2024 | -4.19 Mn |
| Jun 30, 2024 | -3.46 Mn |
| Mar 31, 2024 | -2.27 Mn |
| Dec 31, 2023 | -7.19 Mn |
| Sep 30, 2023 | -3.33 Mn |
| Jun 30, 2023 | 25.29 Mn |
| Mar 31, 2023 | -9.85 Mn |
| Mar 31, 2022 | -444,506.00 |
| Jun 30, 2021 | -452,937.00 |
| Mar 31, 2021 | 533,842.00 |
| Sep 30, 2020 | -1.16 Mn |
| Jun 30, 2020 | -408,872.15 |
| Mar 31, 2020 | -896,464.60 |
| Dec 31, 2019 | -11.59 Mn |
| Mar 31, 2019 | -849,800.46 |